Zomib-based nanomicellar formulation and preparation method therefor

WO2026103292A1PCT designated stage Publication Date: 2026-05-21JIANGSU BIOSCENE PHARMACEUTICAL CO LTD
View PDF 6 Cites 0 Cited by

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
JIANGSU BIOSCENE PHARMACEUTICAL CO LTD
Filing Date
2025-09-08
Publication Date
2026-05-21

Smart Images

  • Figure CN2025119570_21052026_PF_FP_ABST
    Figure CN2025119570_21052026_PF_FP_ABST
Patent Text Reader

Abstract

Provided are a zomib-based nanomicellar formulation and a preparation method therefor. The nanomicellar formulation comprises: carfilzomib, a micelle carrier material, and a stabilizer, wherein the mass ratio of carfilzomib, the micelle carrier material, and the stabilizer is 1:15-30:15-30, and the carrier material is PEG-DSPE. PEG-DSPE is used as a drug carrier to prepare a carfilzomib micelle formulation. The formulation has a particle size of 8-20 nm, has high entrapment efficiency, and has a strong cell penetration capability without being quickly cleared. In addition, the preparation process is simple, without requiring lyophilization. Compared with existing cafilzomib formulations, the toxicity is reduced at the same dosage.
Need to check novelty before this filing date? Find Prior Art